Virtual monitoring in CF - the importance of continuous monitoring in a multi-organ chronic condition.
chronic condition
cystic fibrosis
remote monitoring
review
virtual monitoring
Journal
Frontiers in digital health
ISSN: 2673-253X
Titre abrégé: Front Digit Health
Pays: Switzerland
ID NLM: 101771889
Informations de publication
Date de publication:
2023
2023
Historique:
received:
29
03
2023
accepted:
17
04
2023
medline:
22
5
2023
pubmed:
22
5
2023
entrez:
22
5
2023
Statut:
epublish
Résumé
Cystic Fibrosis (CF) is a chronic life-limiting condition that affects multiple organs within the body. Patients must adhere to strict medication regimens, physiotherapy, diet, and attend regular clinic appointments to manage their condition effectively. This necessary but burdensome requirement has prompted investigations into how different digital health technologies can enhance current care by providing the opportunity to virtually monitor patients. This review explores how virtual monitoring has been harnessed for assessment or performance of physiotherapy/exercise, diet/nutrition, symptom monitoring, medication adherence, and wellbeing/mental-health in people with CF. This review will also briefly discuss the potential future of CF virtual monitoring and some common barriers to its current adoption and implementation within CF. Due to the multifaceted nature of CF, it is anticipated that this review will be relevant to not only the CF community, but also those investigating and developing digital health solutions for the management of other chronic diseases.
Identifiants
pubmed: 37214343
doi: 10.3389/fdgth.2023.1196442
pmc: PMC10192704
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1196442Informations de copyright
© 2023 Vagg, Deasy, Chapman, Ranganathan, Plant and Shanthikumar.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
IEEE J Transl Eng Health Med. 2018 Nov 09;7:2800108
pubmed: 30800534
Pediatr Pulmonol. 1992 Jan;12(1):3-10
pubmed: 1579374
Pediatr Pulmonol. 2020 Sep;55(9):2204-2206
pubmed: 32634297
Stat Med. 2020 Mar 15;39(6):740-756
pubmed: 31816119
Thorax. 2020 Jan;75(1):72-77
pubmed: 31594802
J Cyst Fibros. 2020 Jan;19(1):6-8
pubmed: 32000972
BMC Pulm Med. 2019 Dec 19;19(1):253
pubmed: 31856791
Lancet Respir Med. 2023 Jan;11(1):97-110
pubmed: 36206780
BMC Pediatr. 2018 Oct 23;18(1):335
pubmed: 30352564
J Telemed Telecare. 2018 Sep;24(8):547-552
pubmed: 28799841
Curr Opin Pulm Med. 2021 Nov 1;27(6):544-553
pubmed: 34431789
BMJ Open Respir Res. 2022 Mar;9(1):
pubmed: 35297371
Nutrients. 2021 May 26;13(6):
pubmed: 34073260
Inform Health Soc Care. 2013 Dec;38(4):354-65
pubmed: 23957685
BMJ Open. 2020 Oct 7;10(10):e039587
pubmed: 33033031
JAMIA Open. 2021 Sep 29;4(3):ooab084
pubmed: 34604710
Am J Respir Crit Care Med. 2017 Nov 1;196(9):1144-1151
pubmed: 28608719
Curr Psychol. 2021 Nov 24;:1-14
pubmed: 34840486
J Psychosom Res. 2019 Jan;116:125-130
pubmed: 30579560
BMC Pulm Med. 2019 Jan 24;19(1):21
pubmed: 30678670
J Med Internet Res. 2020 Oct 6;22(10):e16782
pubmed: 32697197
J Cyst Fibros. 2023 Jan;22(1):39-49
pubmed: 35906171
Sci Rep. 2018 Jul 26;8(1):11242
pubmed: 30050169
J Cyst Fibros. 2009 Mar;8(2):91-6
pubmed: 18952504
Internet Interv. 2021 Feb 24;24:100372
pubmed: 33816126
Pilot Feasibility Stud. 2021 Jan 4;7(1):1
pubmed: 33390191
J Cyst Fibros. 2022 Jan;21(1):70-77
pubmed: 34635459
J Cyst Fibros. 2014 May;13 Suppl 1:S23-42
pubmed: 24856775
Analyst. 2020 Mar 2;145(5):1583-1604
pubmed: 31915768
CJC Open. 2021 Dec 23;4(2):133-147
pubmed: 35198931
Clin Respir J. 2010 Apr;4(2):74-82
pubmed: 20565480
J Cyst Fibros. 2022 Nov 16;:
pubmed: 36402730
J Cyst Fibros. 2021 Jan;20(1):133-139
pubmed: 33279467
Thorax. 2014 Dec;69(12):1090-7
pubmed: 25246663